Zusammenfassung
Zur Untersuchung des Skeletts stehen heute zahlreiche spezielle Verfahren zur Verfügung, die bei schwierigen Fällen gezielt eingesetzt werden können. Sie umfassen vor allem radiologische und pathologisch-anatomische Untersuchungsverfahren. Der Pathologe muß sich bei vielen Knochenkrankheiten selbst einen Eindruck von den radiologischen Veränderungen im Knochen machen und braucht deshalb die radiologischen Dokumente (Röntgenbild, CT, Szintigramm, Angiogramm, MRT usw.). Andererseits sollte der Radiologe Kenntnisse von den makro- und histomorphologischen Strukturveränderungen im Knochen haben, um die radiologisch sichtbaren Strukturveränderungen sicher interpretieren und einordnen zu können. Erst durch eine interdisziplinäre Zusammenarbeit kann oft eine sichere Diagnose erstellt werden, wobei klinische Befunde (u. a. Laboruntersuchungen) einbezogen werden müssen.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Literatur
Achilles E, Padberg B-C, Holl K, Klöppel G, Schröder S (1991) Immunocytochemistry of paragangliomas–value of staining for S-100 protein and glial fibrillary acid protein in diagnois and prognosis. Histopathology 18: 453–458
Adler CP (1979) Differential diagnosis of cartilage tumors. Pathol Res Pract 166: 45–58
Adler CP (1979) Extra-osseous osteoblastic osteosarcoma of the right breast. Skeletal Radiol 4: 107–110
Adler CP, Uehlinger E (1979) Grenzfälle bei Knochentumoren. Präneoplastische Veränderungen und Geschwülste
fraglicher Dignität. Verh Dtsch Ges Pathol 63: 352–358
Adler CP, Wenz W (1981) Intraossäre Osteolyseherde. Radiologe 21: 470–479
Adler CP, Genz T (1982) Zytophotometrische Untersuchungen von Knochentumoren. Pathologe 3: 174
Adler CP, Riede UN, Wurdak W, Zugmaier G (1984) Measurements of DNA in Hodgkin Lymphomas and Non-Hodgkin Lymphomas. Path Res Pract 178: 579–589
Adler CP (1986) DNS-Zytophotometrie an Knochentumoren. In: Dietsch P, Keck E, Kruse HP, Kuhlencordt F (Hrsg) Aktuelle Ergebnisse der Osteologie. Osteologica 1: 233–239
Adler CP, Böcking A, Kropff M, Leo ETG (1992) DNS-zytophotometrische Untersuchungen zur Prognose von reaktiver Plasmozytose und Plasmozytom. Verh Dtsch Ges Pathol 76: 303
Adler CP, Herget GW, Neuburger M, Pfisterer J (1995) DNS-Bestimmung von Knochentumoren mit der Flow-Zytometrie und der Einzelzell-Zytophotometrie. Vergleichende Darstellung von Methodik, diagnostischer Wertigkeit und der Interpretation von Histogrammen. Osteologie 4: 1–8
Adler CP, Neuburger M, Herget GW, Pfisterr J (1995) DNSZytophotometrie von Weichteiltumoren vergleichende einzellzytophotometrische und flowzytometrische Messungen an paraffin-eingebettetem Material. Tumordiagn Ther 16: 102–106
Adler CP, Herget GW, Neuburger M (1995) DNS-Zytophotometrie zur Prognosebeurteilung von Osteosarkomen. Tumordiagn Ther 16: 166–169
Adler CP, Herget GW, Neuburger M(1995) Cartilaginous tumors. Prognostic applications of cytophotometric DNA analysis. Cancer 76: 1176–1180
Adler CP, Neuburger M, Herget GW et al. (1996) Cytophotometric DNA analysis of bone tumors. New method for preparing formalin-fixed tissue and the regarding of DNA malignancy grade and its prognostic value. Pathol Res Pract 192: 437–445
Adler CP, Friedburg H, Herget GW et al. (1996) Variability of cardiomyocyte DNA content, ploidy level and nuclear number in mammalian hearts. Virchows Arch 429: 159–164
Alho A, Connor JF, Mankin HJ, Schiller AL, Crawford JC (1983) Assessment of malignancy of cartilage tumors using flow-cytometry. A preliminary report. J Bone Joint Surg 65: 779–785
Altmannsberger M, Alles JU, Fritz H et al. (1986) Mesenchymale Tumormarker. Verh Dtsch Ges Pathol 70: 51–63
Altmannsberger M, Weber K, Droste R, Osborn M (1985) Desmin is a specific marker for rhabdomyosarcomas of human and rat origin. Am J Pathol 118: 85–95
Ambros IM, Ambros PF, Strehl S et al. (1991) MIC2 is a specific marker for Ewing’s sarcoma and peripheral primitive neuroectodermal tumors. Evidence for a common histogenesis of Ewing’s sarcoma and peripheral primitive neuroectodermal tumors from MIC2 expression and specific chromosome aberration. Cancer 67: 1886–1893
Atkin NB, Kay R (1979) Prognostic significance of modal DNA value and other factors in malignant tumours, based on 1465 cases. Br J Cancer 40: 210–221
Bauer HC, Kreicbergs A, Silfversward C (1989) Prognostication including DNA analysis in osteosarcoma. Acta Orthop Scand 60: 353–360
Bauer HC (1993) Current status of DNA cytometry in osteosarcoma. Cancer Treatm Res 62: 151–161
Bauer HC (1988) DNA Cytometry of osteosarcoma. Acta Scand 59 [Suppl 11: 1–39
Bauer TW, Tubbs RR, Edinger MG et al. (1989) A prospective comparison of DNA quantitation by image and flow cytometry. J Clin Pathol 92: 322–326
Bengtsson A, Grimelius L, Johannsson H, Pontén J (1977) Nuclear DNA-content of parathyroid cells in adenomas, hyperplastic and normal glands. Acta Path Microbiol Scand [Sect A] 85: 455–460
Böcking A (1981) Grading des Prostatakarzinoms. Habilitationssschrift, Freiburg
Böcking A (1982) Algorithmus für ein universelles DNSMalignitätsgrading. Verh Dtsch Ges Path 66: 540
Böcking A, Sommerkamp H (1980) Malignitäts-Grading des Prostatakarzinoms durch Analyse der Ploidieverteilung, XXXII. Kongr Dtsch Ges Urol (10.-13.9.80), Berlin
Böcking A (1990) DNA-Zytometrie und Automatisation in der klinischen Diagnostik. Verh Dtsch Ges Path 74: 176–185
Böhm N, Sandritter W (1975) DNA in human tumors: A cytophotometric study. In: Grundmann E, Kirsten WH (eds) Current topics in pathology. Springer, Berlin Heidelberg New York, S 151–219
Bosse A, Vollmer E, Böcker W et al. (1990) The impact of osteonectin for differential diagnosis of bone tumors. An immunohistochemical approach. Pathol Res Pract 186: 651–657
Brooks JP, Pascal RR (1984) Malignant giant cell tumor of bone: ultrastructural and immunohistologic evidence of histiocytic origin. Hum Pathol 15: 1098–1100
Brooks J (1982) Immunohistochemistry of soft tissue tumors. Myoglobin as a tumor marker for rhabdomyosarcoma. Cancer 50: 1757–1763
Brown DC, Theaker JM, Banks PM (1987) Cytokeratin expression in smooth muscle and smooth muscle tumors. Histopathology 11: 477–486
Bunn PA, Krasnow S, Makuch RW et al. (1982) Flow cytometric analysis of DNA content of bone marrow cells in patients with plasma cell myeloma: Clinical implications. Blood 59: 528–535
Caspersson T (1936) Über den chemischen Aufbau der Strukturen des Zellkernes. Skand Arch Physiol 73 [Suppl 8]: 1–151
Colvin RB, Bhan AK, McCluskey RT (1988) (eds) Diagnostic immunopathology. Raven, New York
Cuvelier CA, Roels HJ (1979) Cytophotometric studies of the nuclear DNA content incartilaginous tumors. Cancer 44: 1363–1374
Dierick AM, Langlois M, van Oostveldt P, Roels H (1993) The prognostic significance of the DNA content in Ewing’s sarcoma: a retrospective cytophotometric and flow cytometric study. Histopathol 23: 333–339
Eneroth CM, Zetterberg A (1973) Microspectrophotometric DNA content as a criterion of malignancy in salivary gland tumors of the oral cavity. Acta Otorhinolaryngol (Stockholm) 75: 296–298
Engler H, Thürlimann B, Riesen WF (1996) Biochemical markers of bone remodelling. Onkologie 19: 126–131
Eusebi V, Ceccarelli C, Gorza L et al. (1986) Immunocytochemistry of rhabdomyosarcoma. The use of four different markers. Am J Surg Pathol 10: 293–299
Födisch HJ, Mikuz G, Walter N (1974) Cytophotometrische Untersuchungen an Knochengeschwülsten. Verh Dtsch Ges Pathol 58: 425–429
Frohn A, Födisch HJ, Bode U (1986) Fluorescense cytophotometric DNA studies of Ewing and osteosarcoma. Klin Pädiatr 198: 262–266
Gatter KC (1989) Diagnostic immunocytochemistry: achievements and challenges. J Pathol 159: 183–190
Gatter KC, Alcock C, Heryet A, Mason DY (1985) Clinical importance of analysing malignant tumours of uncertain origin with immunohistological techniques. Lancet I: 1302–1305
Genz T, Böcking A, Adler CP (1983) DNS-Malignitätsgrading an Knochentumoren. Verh Dtsch Ges Pathol 67: 697
Hämmerli G, Sträuli P, Schlüter G (1968) Deoxyribonucleic acid measurements in nodular lesions of the human thyroid. Lab Invest 18: 675–680
Hashimoto H, Daimaru Y, Enjoji M (1984) 5–100 protein distribution in liposarcoma. An immunoperoxidase study with special reference to the distinction of liposarcoma from myxoid malignant fibrous histiocytoma. Virchos Arch A 405: 1–10
Hauenstein FH, Wimmer B, Beck A, Adler CP (1988) Knochenbiopsie unklarer Knochenläsionen mit einer 1,4 mm messenden Biopsiekanüle. Radiologe 28: 251–256
Helio H, Karaharju E, Nordling S (1985) Flow cytometric determination of DNA content in malignant and benign bone tumors. Cytometry 6: 165–171
Hofstädter F, Jakse G, Lederer B, Mikuz G (1980) Cytophotometric investigations of the DNA-content of transitional cell tumours of the bladder. Pathol Res Pract 167: 254–264
Kahn HJ, Marks A, Thom H, Baumal R (1983) Role of antibody to S-100 protein in diagnostic pathology. Am J Clin Pathol 79: 341–347
Kreicbergs A, Cewrien R, Tribukait B, Zetterberg A (1981) Comparative single-cell and flow DNA analysis of bone sarcoma. Anal Quant Cytol Histol 3: 121–127
Kreicbergs A, Silvfersward C, Tribukait B (1984) Flow DNA analysis of primary bone tumors. Relationship between cellular DNA content and histopathological classification. Cancer 53: 129–136
Kropff M, Leo E, Steinfurth G et al. (1991) DNA-zytophotometrischer Nachweis von Aneuploidie, erhöhter Proliferation und Kernfläche als frühe Marker prospektiver Malignität bei monoklonales Gammopathie unklarer Signifikanz ( MGUS ). Verh Dtsch Ges Pathol 75: 480
Kropff M, Leo E, Steinfurth G et al. (1994) DNA-image cytometry and clinical staging systems in multiple myeloma. Anticancer Res 14: 2183–2188
Lederer B, Mikuz G, Gütter W, Nedden G zur (1972) Zytophotometrische Untersuchungen von Tumoren des Übergangsepithels der Harnblase. Vergleich zytophotometrischer Untersuchungsergebnisse mit dem histologischen Grading. Beitr Pathol Anat 147: 379–389
Leo E, Kropff M, Lindemann A et al. (1995) DNA aneuploidy, increased proliferation and nuclear area of plasma cells in monoclonal gammopathy of undetermined significance and multiple myeloma. Anal Quant Cytol Histol 17: 113–120
Leong A S-Y (1993) Applied immunohistochemistry for the surgical pathologist. Edwar Arnold, London
Lizard-Nacol S, Lizard G, Justrabo E, Turc-Çarel C (1989) Immunologic characterization of Ewing’s sarcoma using mesenchymal and neural markers. Am J Pathol 135: 847–855
Look AT, Douglass EC, Meyer WH (1988) Clinical importance of near-diploid tumor stem lines in patients with osteosarcoma of an extremity. N Engl J Med 318: 1567–1572
Mason DY, Gatter KC (1987) The role of immunocytochemistry in diagnostic pathology. J Clin Pathol 40: 1042–1054
Matsumou H, Shimoda T, Kakimoto S et al. (1985) Histopathologic and immunohistochemical study of malignant tumors of peripheral nerve sheath (malignant schwan-noma). Cancer 56: 2269–2279
McElroy HH, Shih M-S, Parfitt AM (1993) Producing frozen sections of calcified bone. Biotech Histochem 68: 50–55
Mellin W (1990) Cytophotometry in tumor pathology. A critical review of methods and application, and some results of DNA-analysis. Pathol Res Pract 186: 37–62
Michie SA, Spagnolo DV, Dunn KA et al. (1987) A panel approach to the evaluation of the sensitivity and specificity of antibodies for the diagnosis of routinely processed, histologically undifferentiated human neoplasm. Am J Clin Pathol 88: 457–462
Moore GW, Riede UN, Sandritter W (1977) Application of Quine’s nullities to a quantitative organelle pathology. J Theor Pathol 65: 633–651
Moore GW, Hutchins GM, Bulkley BH (1979) Certainity levels in the nullity method of symbolic logic: Application to the pathogenesis of congenital heart malformations. J Theor Biol 76: 53–81
Neuburger M, Herget GW, Adler CP (1996) Liposarcoma–Comparison of flow-cytometric and image-cytophotometric DNA measurements. Oncol Rep 3: 559–562
Neumann K, Ramaswamy A, Schmitz-Moormann P (1990) Immunhistochemie der Weichteiltumoren. Tumordiagn Ther 11: 120–124
Norton AJ, Thomas JA, Isaacson PG (1987) Cytokeratinspecific monoclonal antibodies are reactive with tumors of smooth muscle derivation. An immunocytochemical and biochemical study using antibodies to intermediate filament cytoskeletal proteins. Histopathology 11: 487–499
Otto HF, Berndt R, Schwechheimer K, Möller P (1987) Mesenchymal tumor markers: special proteins and enzymes. In: Seifert G (ed) Morphological tumor markers. Gurr Top Pathol 77: 179–205
Overbeck J von, Staehli C, Gudat F (1985) Immunohistochemical characterization of an anti-epithelial monoclonal antibody (mAB Lu-5). Virchos Arch 407: 1–12
Park Y-K, Yang MH, Park HR (1996) The impact of osteonectin for differential diagnosis of osteogenic bone tumors: an immunohistochemical and in situ hybridization approach. Skeletal Radiol 25: 13–17
Reiser M, Semmler W (1997) Magnetresonanztomographie, 2. Aufl. Springer, Berlin Heidelberg New York Tokyo
Robinson M, Alcock C, Gatter KC, Mason DY (1988) The analysis of malignant tumours of uncertain origin with immunohistological techniques: clinical follow-up. Clin Radiol 39: 432–434
Sandritter W (1958) Ultraviolett-Mikrospektrophotometrie. In: Graumann W, Neumann K (Hrsg) Hdb. der Histochemie, Bd I/1. Fischer, Stuttgart, S 220–338
Sandritter W (1961) Methoden und Ergebnisse der quantitativen Histochemie. Dtsch Med Wochenschr 45: 2177–2183
Sandritter W, Carl M, Ritter W (1966) Cytophotometric measurements of DNA content of human malignant tumors by means of the Feulgen reaction. Acta Cytol (Philadelphia) 10: 26–30
Sandritter W, Adler CP (1972) A method for determing cell number on organs with polpoid cell nuclei. Beitr Pathol Anat 146: 99–103
Sandritter W, Kiefer G, Kiefer R et al. (1974) DNA in heterochromatin. Cytophotometric pattern recognition image analysis among cell nuclei in duct epithelium and in carnima of the human breast. Beitr Pathol Anat 151: 87–96
Sandritter W (1977) Zytophotometrie. Verh Anat Ges (Jena): 59–73
Sandritter W (1981) Quantitative pathology in theory and practice. Pathol Res Pract 171: 2–21
Sasaki K, Murakami T (1992) Clinical application of flow cytometry for DNA analysis of solid tumors. Acta Pathol Jpn 42: 1–14
Schulz A, Jundt G (1989) Immunohistological demonstration of osteonectin in normal bone tissue and in bone tumors. Curr Top Pathol 80: 31–54
Schulz A, Jundt G, Berghauser K-H et al. (1988) Immunohistochemical study of osteonectin in various types of osteosarcoma. Am J Pathol 132: 233–238
Schürch W, Skalli O, Lagacé R (1990) Intermediate filament proteins and actin isoforms as markers for soft-tissue tumor differentiation and origing. III Hemangiopericytomas and glomus tumors. Am J Pathol 136: 771–786
Schütte B, Reynders MM, Bosman FT, Blijham GH (1985) Flow cytometric DNA ploidy level in nuclei isolated from paraffin-embedded tissue. Cytometry 6: 26–30
Seidel A, Sandritter W (1963) Cytophotometrische Messungen des DNS-Gehaltes eines Lungenadenoms und einer malignen Lungenadenomatose. Z Krebsforsch 65: 555–559
Shankey TV, Rabinovitch PS, Bagwell B (1993) Guidelines for implementation of clinical DNA cytometry. Cytometry 14: 472–477
Siefert G (1987) Morphological tumor markers. Springer, Berlin Heidelberg New York Tokyo
Sun D, Biesterfeld S, Adler CP, Böcking A (1992) Prediction of recurrence in giant cell bone tumors by DNA cytometry. Anal Quant Cytol 14: 341–346
Tavares AS, Costa J, De Carvalho A, Reis M (1966) Tumor ploidy and prognosis in carcinomas of the bladder and prostate. Br J Cancer 20: 438–441
Tienhaara A, Pelliniemi TT (1992) Flow cytometric DNA analysis and clinical correlation in multiple myeloma. Am J Clin Pathol 97: 322–330
Uehlinger E (1974) Pathologische Anatomie der Knochengeschwülste (unter besonderer Berücksichtigung der semimalignen Formen). Chirurg 45: 62–70
Valen F van, Prior R, Wechsler W et al. (1988) Immunzytochemiche und biochemische Untersuchungen an einer Ewing-Sarkom-Zellinie: Hinweise für eine neurale In-vitro-Differenzierung. KIM Pädiatr 200: 267–270
Weiss SW, Langloss JM, Enzinger FM (1983) Value of S-100 protein in the diagnosis of soft tissue tumors with particular reference to benign and malignant Schwann cell tumors. Lab Invest 49: 299–308
Werner M, Rieck J, Heintz A, Pösl M, Delling G (1996) Vergleichende DNA-zytometrische und zytogenetische Ploidiebestimmungen an Chondrosarkomen und Osteosarkomen. Pathologe 17: 374–379
Wersto RP, Liblit RL, Koss LG (1991) Flow cytometric DNA analysis of human solid tumors: A review of the interpretation of DNA histograms. Hum Pathol 22: 1085–1098
Wick MR, Siegal GP (1988) Monoclonal antibodies in diagnostic immunohistochemistry. Marcel Dekker, New York
Zollinger HU (1946) Geschwulstprobleme. Gut-und Bösartigkeit der Geschwülste. Vjschr Naturforsch Ges 91: 81–94
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 1998 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Adler, CP. (1998). Untersuchungstechniken. In: Knochenkrankheiten. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-12160-3_16
Download citation
DOI: https://doi.org/10.1007/978-3-662-12160-3_16
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-662-12161-0
Online ISBN: 978-3-662-12160-3
eBook Packages: Springer Book Archive